Drug importation is likely to advance regardless of the election’s outcome, but the future of price-inflation caps and international reference pricing is uncertain and Medicare price negotiation will not happen unless Democrats win the White House and both chambers of Congress, according to the Biotechnology Industry Organization. Both Democratic presidential nominee Joe Biden and President Donald Trump support letting states import Canadian prescription drugs. The White House budget office began reviewing Thursday (Sept. 10) a final rule for state drug...